Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002052113-25-001674·ADC Therapeutics SA
Schedule 13G ownership disclosure
ADC THERAPEUTICS SA
Common Stock · CUSIP: H0036K147
Event date: 2025-03-31
- Filing-level shares
- 4,913,153.00
- Percent of class
- 5.0%
- BlackRock, Inc.
Shares: 4,913,153.00 · Class: 5.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-001674
- Form type
- SCHEDULE 13G/A
- Filer
- ADC Therapeutics SA
- CIK
- CIK 1771910
- Filed
- Apr 24, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership